A phase II trial of hepatic ablation of metastases to modulate and enhance immunotherapy response in non-small cell lung cancer (HAMMER-NSCLC)
Adam J. Schoenfeld, Christopher H. Crane, Melissa Zinovoy, Matthew Joseph Bott et al.
Journal
BMC Cancer
Topics
Cancer Immunotherapy and Biomarkers
article
A phase II trial of hepatic ablation of metastases to modulate and enhance immunotherapy response in non-small cell lung cancer (HAMMER-NSCLC)
Adam J. Schoenfeld, Christopher H. Crane, Melissa Zinovoy, Matthew Joseph Bott, Dennis M. Sopka, D.A. Roth O'Brien, Mithat Gönen, Marsha Reyngold, Paul Bernard Romesser, Daniel Richard Gomez, Matthew T. McMillan, John Cuaron, Adeel Kaiser, Vonetta M. Williams
article en
Abstract
No abstract available for this paper.
Publication Tag
BMC CancerVol. 25(1)
Institutions
Lehigh Valley Hospital-Pocono (US), Memorial Sloan Kettering Cancer Center (US), Lehigh Valley Health Network (US)